The special purpose acquisition company (SPAC) market has exploded. According to CNBC, funds raised via U.S. SPACs totaled $87.9 billion at the end of the first quarter of 2021, exceeding the $83.4 billion issuance in 2020. However, despite their popularity, SPACs come with certain risk factors, including risks that can impact a company’s executives and […]
Bitcoin. Ethereum. Binance Coin. When it comes to digital assets, investors have a growing number of choices. In fact, at the end of May, there were 10,115 different types of cryptocurrencies available — a number that continues to increase daily. However, when it comes to volume, Bitcoin and Ethereum currently hold better than 60% of […]
The insurance industry is continuing to experience an increase in D&O-related claims and lawsuits due to the pandemic. A more prevalent issue involves accusations that a company’s executive management or directors and officers allegedly contributed to the drop in stock price or other negative financial consequences triggered by COVID-19-related issues. As these lawsuits become more […]
A review of federal securities class actions revealed that there were 97 new D&O class action securities cases filed against life science companies in 2019, accounting for nearly 24% of all new filings that year — a 13% increase from 2018. In fact, 2019 saw the fifth-highest number of D&O filings since 1996.
Consultations: